Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glofitamab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04980222
What this trial is testing

Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Hoffmann-La Roche 46
Testing effectiveness (Phase 2)Looking for participantsNCT06252675
What this trial is testing

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University of California, San Francisco 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06665217
What this trial is testing

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Navy General Hospital, Beijing 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07480850
What this trial is testing

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT07257055
What this trial is testing

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

Who this might be right for
Phase 2 StudyMCLBTKi+2 more
M.D. Anderson Cancer Center 30
Not applicableNot Yet RecruitingNCT07472621
What this trial is testing

Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Henan Cancer Hospital 20
Not applicableUnknownNCT06497452
What this trial is testing

Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

Who this might be right for
B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231250
What this trial is testing

Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaChemo-free TherapyBispecific Antibody
Li Zhiming 40
Testing effectiveness (Phase 2)Looking for participantsNCT06634589
What this trial is testing

Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
B-cell MalignancyRelapsed CancerRefractory Cancer+1 more
BeOne Medicines 80
Not applicableNot Yet RecruitingNCT07498920
What this trial is testing

Gut Microbiome in DLBCL Treated With Glofitamab

Who this might be right for
DLBCLGlofitamabGut Biome
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06996132
What this trial is testing

Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Aggressive B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 25
Early research (Phase 1)Study completedNCT05364424
What this trial is testing

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Looking for participantsNCT07514169
What this trial is testing

The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL

Who this might be right for
Large B-Cell Lymphoma (LBCL)
Ruijin Hospital 30
Not applicableStudy completedNCT05927558
What this trial is testing

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

Who this might be right for
B-cell Non Hodgkin LymphomaRelapseRefractory Lymphoma
Gruppo Italiano Malattie EMatologiche dell'Adulto 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04077723
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche 498
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634289
What this trial is testing

Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Relapsed /Refractory DLBCL
Olivia Newton-John Cancer Research Institute 40
Testing effectiveness (Phase 2)Looking for participantsNCT06651853
What this trial is testing

Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL

Who this might be right for
Diffuse Large B-cell LymphomaRelapsed and Refractory
The First Affiliated Hospital of Xiamen University 22
Testing effectiveness (Phase 2)Looking for participantsNCT06765317
What this trial is testing

Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell Lymphoma
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT06054776
What this trial is testing

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
City of Hope Medical Center 40
Early research (Phase 1)Ended earlyNCT05219513
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche 53
Next Page